High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · see citing works

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216 · see citing works

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works

Elevated C-reactive protein levels in overweight and obese adults

Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494 · see citing works

C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?

Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465 · see citing works

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · see citing works

Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome

Festa, A., D’Agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,363 · see citing works

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354 · see citing works

Molecular Bases of the Acute Coronary Syndromes

Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029 · see citing works

Homocysteine and Atherothrombosis

Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997 · see citing works

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952 · see citing works

Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,941 · see citing works

A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians

Stampfer, M. J. (1992) · JAMA · doi:10.1001/jama.1992.03490070059042 · Cited by 1,705 · see citing works

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · see citing works

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642 · see citing works

Oxford Textbook of Medicine.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_7 · Cited by 1,583 · see citing works

Production of C-reactive protein and risk of coronary events in stable and unstable angina

Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511 · see citing works

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488 · see citing works

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & D, E. B. M. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,479 · see citing works

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389 · see citing works

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,221 · see citing works

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098 · see citing works

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,012 · see citing works

Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.5.425 · Cited by 973 · see citing works

Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction

Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934 · see citing works

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project

Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836 · see citing works

C-Reactive Protein as a Cardiovascular Risk Factor

Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833 · see citing works

Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications

Macy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797 · see citing works

C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., & D, E. B. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00136-3 · Cited by 780 · see citing works

Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease

Fichtlscherer, S., Rosenberger, G., Walter, D. H., Breuer, S., Dimmeler, S., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.102.9.1000 · Cited by 665 · see citing works

Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660 · see citing works

Evaluation of Nine Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2

Roberts, W. L., Moulton, L., Law, T. C., Farrow, G., Cooper-Anderson, M., Savory, J., & Rifai, N. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.418 · Cited by 652 · see citing works

Body mass index, diabetes, and C-reactive protein among U.S. adults.

Ford, E. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1971 · Cited by 645 · see citing works

Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay

Rifai, N., Tracy, R. P., & Ridker, P. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.12.2136 · Cited by 613 · see citing works

Homocyst(e)ine, Diet, and Cardiovascular Diseases: A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association

Malinow, M. R., Bostom, A. G., & Krauss, R. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.178 · Cited by 586 · see citing works

Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability

Biasucci, L. M., Liuzzo, G., Grillo, R. L., Caligiuri, G., Rebuzzi, A. G., Buffon, A., Summaria, F., Ginnetti, F., Fadda, G., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.7.855 · Cited by 581 · see citing works

C-Reactive Protein in the Arterial Intima

Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J. L., Köenig, W., Schmitz, G., Hombach, V., & Torzewski, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2094 · Cited by 581 · see citing works

Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease

Toss, H., Lindahl, B., Siegbahn, A., Wallentin, L. C., & for the FRISC Study Group (1997) · Circulation · doi:10.1161/01.cir.96.12.4204 · Cited by 519 · see citing works

Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein

Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 442 · see citing works

Long-term Exercise and Atherogenic Activity of Blood Mononuclear Cells in Persons at Risk of Developing Ischemic Heart Disease

Smith, J. K. (1999) · JAMA · doi:10.1001/jama.281.18.1722 · Cited by 420 · see citing works

Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults

Ockene, I. S., Matthews, C. E., Rifai, N., Ridker, P. M., Reed, G. W., & Stanek, E. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.444 · Cited by 411 · see citing works

Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects

Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Price, N., Dinges, D. F., & Mullington, J. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.426 · Cited by 410 · see citing works

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

Mendall, M. A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1982 · Cited by 359 · see citing works

Infections, Inflammation, and the Risk of Coronary Heart Disease

Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivanen, P., Leinonen, M., Saikku, P., Tenkanen, L., Manninen, V., Hovi, T., & Mänttäri, M. (2000) · Circulation · doi:10.1161/01.cir.101.3.252 · Cited by 347 · see citing works

Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial

Evans, R. G., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342 · see citing works

Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?

Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323 · see citing works

Analytical Evaluation of Particle-Enhanced Immunonephelometric Assays for C-Reactive Protein, Serum Amyloid a and Mannose-Binding Protein in Human Serum

Ledue, T. B., Weiner, D. L., Sipe, J. D., Poulin, S. E., Collins, M. F., & Rifai, N. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500607 · Cited by 321 · see citing works

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.

Chasan‐Taber, L., Selhub, J., Rosenberg, I. H., Malinow, M. R., Terry, P., Tishler, P. V., Willett, W. C., Hennekens, C. H., & Stampfer, M. J. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10718578 · Cited by 273 · see citing works

Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency: A Randomized, Controlled Clinical Trial

Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257 · see citing works

Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women

Ridker, P. M. (1999) · JAMA · doi:10.1001/jama.281.19.1817 · Cited by 255 · see citing works

Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the Moon

Maseri, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361409 · Cited by 228 · see citing works

Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women

Cushman, M., Meilahn, E. N., Psaty, B. M., Kuller, L. H., Dobs, A. S., & Tracy, R. P. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.893 · Cited by 218 · see citing works

Increased C-reactive Protein Levels during Short-term Hormone Replacement Therapy in Healthy Postmenopausal Women

van Baal, M., Kenemans, P., van der Mooren, M. J., van Kessel, H. I., EMEIS, J. J., & Stehouwer, C. D. A. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614600 · Cited by 140 · see citing works

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724 · see citing works

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works

Staging and grading of periodontitis: Framework and proposal of a new classification and case definition

Tonetti, M. S., Greenwell, H., & Kornman, K. S. (2018) · Journal of Periodontology · doi:10.1002/jper.18-0006 · Cited by 3,239 · see citing works

DNA methylation GrimAge strongly predicts lifespan and healthspan

Lu, A. T., Quach, A., Wilson, J. G., Reiner, A. P., Aviv, A., Raj, K., Hou, L., Baccarelli, A. A., Li, Y., Stewart, J. D., et al. (2019) · Aging · doi:10.18632/aging.101684 · Cited by 2,540 · see citing works

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · see citing works

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557 · see citing works

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk

Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Regan, M. M., Price, N. J., Dinges, D. F., & Mullington, J. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.050 · Cited by 1,195 · see citing works

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease

Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094 · see citing works

The role of vagal function in the risk for cardiovascular disease and mortality

Thayer, J. F., & Lane, R. D. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2005.11.013 · Cited by 1,033 · see citing works

Staging and grading of periodontitis: Framework and proposal of a new classification and case definition

Tonetti, M. S., Greenwell, H., & Kornman, K. S. (2018) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12945 · Cited by 1,033 · see citing works

Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea

Shamsuzzaman, A. S. M., Winnicki, M., Lanfranchi, P., Wolk, R., Kara, T., Accurso, V., & Somers, V. K. (2002) · Circulation · doi:10.1161/01.cir.0000018948.95175.03 · Cited by 974 · see citing works

Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease: A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation

Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934 · see citing works

Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation

Mullington, J. M., Haack, M., Toth, M., Serrador, J. M., & Meier-Ewert, H. K. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.10.003 · Cited by 783 · see citing works

New Markers of Inflammation and Endothelial Cell Activation: Part I

Szmitko, P. E., Wang, C.-H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000089190.95415.9f · Cited by 738 · see citing works

Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study

Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710 · see citing works

Beyond Heart Rate Variability: Vagal Regulation of Allostatic Systems

THAYER, J. F., & STERNBERG, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.014 · Cited by 703 · see citing works

Sleep loss and inflammation

Mullington, J. M., Simpson, N. S., Meier-Ewert, H. K., & Haack, M. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.08.014 · Cited by 519 · see citing works

Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial

Nicklas, B. J., Ambrosius, W., Messier, S. P., Miller, G. D., Penninx, B. W., Loeser, R. F., Palla, S., Bleecker, E., & Pahor, M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.544 · Cited by 443 · see citing works

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000073313.16135.21 · Cited by 427 · see citing works

Relation between markers of systemic vascular inflammation and smoking in women

Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., & Ridker, P. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02284-1 · Cited by 385 · see citing works

The evolving role of inflammation in obesity and the metabolic syndrome

Lee, Y.-H., & Pratley, R. E. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0071-7 · Cited by 369 · see citing works

Reduction in C-reactive protein through cardiac rehabilitation and exercise training

Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302 · see citing works

Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion–biology relationships

O’Donovan, A., Hughes, B. M., Slavich, G. M., Lynch, L., Cronin, M.-T., O’Farrelly, C., & Malone, K. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.03.003 · Cited by 296 · see citing works

Effect of acute sleep deprivation on vascular function in healthy subjects

Sauvet, F., Leftheriotis, G., Gomez-Merino, D., Langrume, C., Drogou, C., Van Beers, P., Bourrilhon, C., Florence, G., & Chennaoui, M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00851.2009 · Cited by 268 · see citing works

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

Saraheimo, M., Teppo, A.-M., Forsblom, C., Fagerudd, J., & Groop, P.-H. (2003) · Diabetologia · doi:10.1007/s00125-003-1194-5 · Cited by 255 · see citing works

Sleep duration, cardiovascular disease, and proinflammatory biomarkers

Grandner, M., Sands-Lincoln, Pak, & Garland (2013) · Nature and Science of Sleep · doi:10.2147/nss.s31063 · Cited by 246 · see citing works

Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level

King, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.5.502 · Cited by 241 · see citing works

Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group

Grandner, M. A., Buxton, O. M., Jackson, N., Sands-Lincoln, M., Pandey, A., & Jean-Louis, G. (2013) · SLEEP · doi:10.5665/sleep.2646 · Cited by 178 · see citing works

Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI study

Elosua, R., Bartali, B., Ordovas, J. M., Corsi, A. M., Lauretani, F., Ferrucci, L., & on Behalf of the InCHIANTI Investigators (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.6.760 · Cited by 171 · see citing works

Radiation dose-dependent increases in inflammatory response markers in a-bomb survivors

Hayashi, T., Kusunoki, Y., Hakoda, M., Morishita, Y., Kubo, Y., Maki, M., Kasagi, F., Kodama, K., Macphee, D. G., & Kyoizumi, S. (2003) · International Journal of Radiation Biology · doi:10.1080/0955300021000038662 · Cited by 172 · see citing works

Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy

Kheirandish-Gozal, L., Capdevila, O. S., Tauman, R., & Gozal, D. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26589 · Cited by 160 · see citing works

C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones

Nesto, R. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01296.x · Cited by 140 · see citing works

Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?

Wilund, K. R. (2007) · Clinical Science · doi:10.1042/cs20060368 · Cited by 138 · see citing works

Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans

Tricon, S., Burdge, G. C., Kew, S., Banerjee, T., Russell, J. J., Grimble, R. F., Williams, C. M., Calder, P. C., & Yaqoob, P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1626 · Cited by 111 · see citing works

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

Olshansky, B., Chung, M. K., Budoff, M. J., Philip, S., Jiao, L., Doyle, Jr., Copland, C., Giaquinto, A., Juliano, R. A., & Bhatt, D. L. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa117 · Cited by 103 · see citing works

Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients

Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn326 · Cited by 102 · see citing works

Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?

Boos, C. J., & Lip, G. Y. H. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001858 · Cited by 84 · see citing works

Atrial fibrillation in athletes: Implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism

Swanson, D. R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.006 · Cited by 81 · see citing works

The differential impact of subjective and objective aspects of social engagement on cardiovascular risk factors

Kamiya, Y., Whelan, B., Timonen, V., & Kenny, R. A. (2010) · BMC Geriatrics · doi:10.1186/1471-2318-10-81 · Cited by 54 · see citing works

Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism

Bilgir, O., Bilgir, F., Calan, M., Calan, O. G., & Yuksel, A. (2015) · Clinics · doi:10.6061/clinics/2015(02)05 · Cited by 54 · see citing works

The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure

Madsen, T., Schmidt, E. B., & Christensen, J. H. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.03.003 · Cited by 52 · see citing works

Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients

Asakura, T., Funatsu, Y., Ishii, M., Namkoong, H., Yagi, K., Suzuki, S., Asami, T., Kamo, T., Fujiwara, H., Uwamino, Y., et al. (2015) · Respiratory Research · doi:10.1186/s12931-015-0304-5 · Cited by 51 · see citing works

Association between Sleep Quality and C-Reactive Protein: Results from National Health and Nutrition Examination Survey, 2005-2008

Liu, R., Liu, X., Zee, P. C., Hou, L., Zheng, Z., Wei, Y., & Du, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092607 · Cited by 47 · see citing works

Effect of <scp>M</scp>etformin compared with hypocaloric diet on serum <scp>C</scp>‐reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome

Esfahanian, F., Zamani, M. M., Heshmat, R., & Moini nia, F. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.02051.x · Cited by 38 · see citing works

Arterial stiffness is increased in young women with endometriosis

Tani, A., Yamamoto, S., Maegawa, M., Kunimi, K., Matsui, S., Keyama, K., Kato, T., Uemura, H., Kuwahara, A., Matsuzaki, T., et al. (2015) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2014.992871 · Cited by 37 · see citing works

Association between anxiety and C-reactive protein levels in stable coronary heart disease patients

Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.4.347 · Cited by 37 · see citing works

Uvulopalatopharyngoplasty decreases levels of C-reactive protein in patients with obstructive sleep apnea syndrome

Kinoshita, H., Shibano, A., Sakoda, T., Ikeda, H., Iranami, H., Hatano, Y., & Enomoto, T. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.07.004 · Cited by 29 · see citing works

A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis

Vodolazkaia, A., Bossuyt, X., Fassbender, A., Kyama, C. M., Meuleman, C., Peeraer, K., Tomassetti, C., & D'Hooghe, T. M. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-113 · Cited by 28 · see citing works

New Clinical Markers Predictive of Cardiovascular Disease: The Role of Inflammatory Mediators

Rackley, C. E. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000126083.86717.5b · Cited by 14 · see citing works

The Effect of Weight Loss on C-Reactive Protein: A Systematic Review

Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.31 · Cited by 5 · see citing works

[Aspirin in cardiovascular prevention: does the approach differ by gender?].

Temizhan, A. (2007) · PubMed · Cited by 2 · see citing works

Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease

Thobani, A., Dhindsa, D. S., DeMoss, B., Raad, M., Sandesara, P. B., Sperling, L. S., & Baer, J. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.08.040 · Cited by 13 · see citing works

Aspirin for Primary Prevention of Cardiovascular Disease

Kim, J. H., Shim, M. J., Lee, S., Oh, J., & Kim, S. H. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.162 · Cited by 7 · see citing works

Appropriate Use of Aspirin in the Primary and Secondary Prevention: Results From the ASSOS StudyPreprint

Çelik, O., Çil, C., Başaran, Ö., et al. (2022) · doi:10.22541/au.164864769.91331063/v1

Aspirin for primary prevention of cardiovascular disease?

BMJ Publishing Group Ltd (2010) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.15.1.31 · Cited by 2 · see citing works